P. Andrés‐Benito

发表

TDP-43 Vasculopathy in the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis (sALS) and Frontal Cortex in sALS/FTLD-TDP

I. Ferrer, M. Carmona, M. Povedano, 2021, Journal of neuropathology and experimental neurology.

Resveratrol in epilepsy: preventive or treatment opportunities?

M. Pallàs, D. Ortuño-Sahagún, A. Rojas-Mayorquín, 2014, Frontiers in bioscience.

Lipid alterations in human frontal cortex in ALS‐FTLD‐TDP43 proteinopathy spectrum are partly related to peroxisome impairment

I. Ferrer, M. Portero-Otín, R. Pamplona, 2020, Neuropathology and applied neurobiology.

Dual Role of Lysophosphatidic Acid Receptor 2 (LPA2) in Amyotrophic Lateral Sclerosis

J. Chun, I. Ferrer, Anna Martínez-Muriana, 2021, Frontiers in Cellular Neuroscience.

Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model

I. Ferrer, J. D. del Río, J. Fernández-Irigoyen, 2022, International journal of molecular sciences.

Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy

I. Ferrer, J. D. del Río, M. Carmona, 2020, Acta Neuropathologica.

Differences in Tau Seeding in Newborn and Adult Wild-Type Mice

I. Ferrer, J. D. del Río, M. Carmona, 2022, International journal of molecular sciences.

PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies

I. Ferrer, M. Espina, A. Calpena, 2018, International journal of nanomedicine.

Dysregulated Protein Phosphorylation in a Mouse Model of FTLD-Tau.

I. Ferrer, J. D. del Río, J. Fernández-Irigoyen, 2022, Journal of neuropathology and experimental neurology.

Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer‐like symptoms in a transgenic animal model

I. Ferrer, E. Asó, P. Andrés‐Benito, 2018, Biochemical pharmacology.

Altered Dynein Axonemal Assembly Factor 1 Expression in C-Boutons in Bulbar and Spinal Cord Motor-Neurons in Sporadic Amyotrophic Lateral Sclerosis.

I. Ferrer, M. Portero-Otín, M. Povedano, 2019, Journal of neuropathology and experimental neurology.

Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis

I. Ferrer, M. Povedano, R. Domínguez, 2022, International journal of molecular sciences.

Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment

I. Ferrer, Ana Martínez, J. Fernández-Ruiz, 2020, Scientific Reports.

Atypical astroglial pTDP‐43 pathology in astroglial predominant tauopathy

B. Gómez-Anson, D. Lopez-Villegas, R. Sánchez-Valle, 2021, Neuropathology and applied neurobiology.

The motor neuron disease mouse model hSOD1-G93A presents a non-canonical profile of senescence biomarkers in the spinal cord

I. Ferrer, M. Portero-Otín, R. Pamplona, 2020 .

Running title : CB 2 role in cannabis-based therapy for AD

R. Maldonado, M. Carmona, E. Asó, 2017 .

Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.

R. Maldonado, I. Ferrer, M. Carmona, 2016, Journal of Alzheimer's disease : JAD.

Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

M. Portero-Otín, R. Pamplona, M. Jové, 2022, bioRxiv.

Selective brain regional changes in lipid profile with human aging

I. Ferrer, M. Portero-Otín, R. Pamplona, 2022, GeroScience.

Common and Specific Marks of Different Tau Strains Following Intra-Hippocampal Injection of AD, PiD, and GGT Inoculum in hTau Transgenic Mice

I. Ferrer, J. D. del Río, M. Carmona, 2022, International journal of molecular sciences.

Host Tau Genotype Specifically Regulates and Designs Tau Seeding and Spreading Following Intracerebral Injection of Identical Tau ADInoculum

I. Ferrer, M. Carmona, J. Río, 2021 .

Inflammatory Gene Expression in Whole Peripheral Blood at Early Stages of Sporadic Amyotrophic Lateral Sclerosis

I. Ferrer, E. Asó, J. Moreno, 2017, Front. Neurol..

Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology

F. Ciruela, M. Carmona, I. Ferrer, 2017, Neuropathology and applied neurobiology.

Brain pyrimidine nucleotide synthesis and Alzheimer disease

I. Ferrer, E. Ruiz-Pesini, M. Bayona-Bafaluy, 2019, Aging.

Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model.

I. Ferrer, E. Asó, P. Sanz, 2020, Cannabis and cannabinoid research.

Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis

I. Ferrer, I. Zerr, I. Santana, 2020, International journal of molecular sciences.

Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis

I. Ferrer, J. Fernández-Irigoyen, E. Santamaría, 2020, International journal of molecular sciences.

MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology

I. Ferrer, I. Zerr, F. Llorens, 2017, Journal of Molecular Neuroscience.

TREM2 expression in the brain and biological fluids in prion diseases

K. Blennow, B. Mollenhauer, J. D. del Río, 2021, Acta Neuropathologica.

Differential astrocyte and oligodendrocyte vulnerability in murine Creutzfeldt-Jakob disease

I. Ferrer, M. Carmona, O. Andréoletti, 2021, Prion.

YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression

F. Llorens, I. Ferrer, M. Colomina, 2018, Aging.

Assessment of Glial Activation Response in the Progress of Natural Scrapie after Chronic Dexamethasone Treatment

I. Ferrer, J. Badiola, M. Carmona, 2020, International journal of molecular sciences.

Wnt Signaling Alterations in the Human Spinal Cord of Amyotrophic Lateral Sclerosis Cases: Spotlight on Fz2 and Wnt5a

I. Ferrer, C. González-Fernández, P. Andrés‐Benito, 2019, Molecular Neurobiology.

Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model.

I. Ferrer, E. Asó, P. Andrés‐Benito, 2016, Journal of Alzheimer's disease : JAD.

The Presence of Human Herpesvirus 6 in the Brain in Health and Disease

A. Navarro, G. Santpere, I. Ferrer, 2020, Biomolecules.

[A neuropsychological and functional brain imaging study of visuo-imitative apraxia].

P. Peigneux, E. Salmon, M. Van der Linden, 2000, Revue neurologique.

Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease

I. Ferrer, J. D. del Río, R. Pamplona, 2021, Brain pathology.

Combined Transcriptomics and Proteomics in Frontal Cortex Area 8 in Frontotemporal Lobar Degeneration Linked to C9ORF72 Expansion.

I. Ferrer, J. Fernández-Irigoyen, E. Santamaría, 2019, Journal of Alzheimer's disease : JAD.

Gene Expression Profile in Frontal Cortex in Sporadic Frontotemporal Lobar Degeneration-TDP

I. Ferrer, G. Santpere, E. Gelpí, 2018, Journal of neuropathology and experimental neurology.

Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration

I. Ferrer, E. Asó, J. Moreno, 2017, Aging.

Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies

I. Ferrer, Belén Lorente-Galdos, A. Navarro, 2018, Brain pathology.

Amyloid and tau pathology of familial Alzheimer’s disease APP/PS1 mouse model in a senescence phenotype background (SAMP8)

J. del Valle, M. Pallàs, I. Ferrer, 2015, AGE.

White matter alterations in Alzheimer’s disease without concomitant pathologies

P. Andrés‐Benito, I. Ferrer, I. Ferrer, 2020, Neuropathology and applied neurobiology.

Neuroimmune Response Mediated by Cytokines in Natural Scrapie after Chronic Dexamethasone Treatment

I. Ferrer, J. Badiola, M. Carmona, 2021, Biomolecules.

Capacity for Seeding and Spreading of Argyrophilic Grain Disease in a Wild-Type Murine Model; Comparisons With Primary Age-Related Tauopathy

I. Ferrer, J. D. del Río, Vanessa Gil, 2020, Frontiers in Molecular Neuroscience.

Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum

I. Ferrer, J. D. del Río, M. Carmona, 2022, International journal of molecular sciences.

Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology

I. Ferrer, M. Carmona, J. Río, 2021, Neuroscience.

Relevance of host tau in tau seeding and spreading in tauopathies

I. Ferrer, M. Carmona, M. Zelaya, 2020, Brain pathology.

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies

I. Ferrer, J. D. del Río, M. Carmona, 2019, Front. Aging Neurosci..

Altered Regulation of KIAA0566, and Katanin Signaling Expression in the Locus Coeruleus With Neurofibrillary Tangle Pathology

I. Ferrer, P. Andrés‐Benito, R. Delgado-Morales, 2018, Front. Cell. Neurosci..

Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology

I. Ferrer, M. Carmona, J. Río, 2021, Neuroscience.

Proteostatic modulation in brain aging without associated Alzheimer’s disease-and age-related neuropathological changes

J. D. del Río, M. Carmona, J. Fernández-Irigoyen, 2023, Aging.

Deregulated Transcription and Proteostasis in Adult mapt Knockout Mouse

I. Ferrer, J. D. del Río, M. Carmona, 2023, International journal of molecular sciences.

Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression

A. Al-Chalabi, M. Portero-Otín, R. Pamplona, 2021, Brain communications.

Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.

I. Ferrer, M. Portero-Otín, R. Pamplona, 2020, Brain : a journal of neurology.

Nuclear lipidome is altered in amyotrophic lateral sclerosis: A pilot study

I. Ferrer, M. Portero-Otín, R. Pamplona, 2021, Journal of neurochemistry.

Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis

I. Ferrer, M. Portero-Otín, R. Pamplona, 2023, Journal of neurochemistry.

Nuclear lipidome is altered in amyotrophic lateral sclerosis: a preliminary study

M. Portero-Otín, R. Pamplona, I. Ferrer, 2019, bioRxiv.

Primary Feline Tauopathy: Clinical, Morphological, Immunohistochemical, and Genetic Studies

G. Santpere, M. Pumarola, P. Andrés‐Benito, 2023, Animals : an open access journal from MDPI.

Amyloid and tau pathology of familial Alzheimer’s disease APP/PS1 mouse model in a senescence phenotype background (SAMP8)

M. Pallàs, A. Canudas, P. Andrés‐Benito, 2015, AGE.

MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology

I. Ferrer, I. Zerr, F. Llorens, 2017, Journal of Molecular Neuroscience.

Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen

J. Vázquez-Costa, P. Andrés‐Benito, Carla Marco, 2024, International Journal of Molecular Sciences.

miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages.

P. Andrés‐Benito, Laia Lidón, Rosalina Gavín, 2024, Biochimica et biophysica acta. Molecular basis of disease.

Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing–remitting multiple sclerosis: a 20-year follow-up cohort

L. Romero-Pinel, L. Bau, E. Matas, 2023, Journal of neurology.

Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson’s disease

L. Espinosa, L. Blasco-Agell, P. Andrés‐Benito, 2024, JCI insight.